Health-Tech & AI · Dubai & the GCC
Health-tech go-to-market that turns product into pipeline.
A great product is not a business until it reaches the market. SULD partners with health-tech and AI founders across Dubai and the GCC to convert a working platform into commercial traction — the go-to-market, the regulatory clarity, and the distribution into health systems, payers, and providers. We diagnose where the revenue actually lives, design the commercial model around it, and open the doors that founders rarely reach alone. You have built the technology. We build the pipeline that proves it.
Where we make the difference.
Go-to-market strategy
We define the buyer, the model, and the motion that convert a health-tech product into predictable revenue across the GCC.
Regulatory-aware commercialization
We navigate the UAE and GCC digital-health landscape so compliance clears your path to market instead of blocking it.
Distribution and access
We open conversations with the providers, payers, and health systems that founders struggle to reach on their own.
Investor and scale readiness
We shape the traction, narrative, and metrics that make your next raise and your regional expansion credible.
We run the SULD DNA method — Diagnose, Design, Deliver, Sustain.
We diagnose where your product creates real commercial value and who will pay for it, then design a go-to-market and regulatory strategy fitted to the GCC's digital-health reality. We deliver the launch as a partnership — positioning, pilots, distribution, and pipeline — and we sustain it with the metrics, relationships, and growth systems that carry you from first traction to regional scale.
You get an operating partner invested in your revenue, not a vendor invested in a deliverable.
Business Consultancy for health-tech & ai →The SULD DNA methodHealth-Tech & AI — questions answered.
We have a product but no GCC traction — where do you start?
With the commercial reality. We identify who pays, why, and how to reach them, then build the go-to-market, regulatory path, and distribution to convert your platform into a real pipeline across the region.
Can you navigate digital-health regulation in the UAE and GCC?
Yes. We treat regulatory strategy as part of commercialization, mapping the requirements across GCC markets so compliance accelerates market access rather than delaying it.
Are you a development or engineering firm?
No. You build the technology; we build the business around it — strategy, market access, distribution, and pipeline. Where the build ends, that is our starting sign.
